Work

Decline in Bone Mass During Weight Loss: A Cause for Concern?

Year: 2015
Type: article
Abstract: C linicians spend countless hours counseling obese pa- tients about weight loss, and the scientific literature is teeming with studies comparing the effectiveness of diets for attaining and maintaining weight loss in the setting of obesity.Among bone and mineral researchers, there is increasing interest in understanding the skeletal effects of both obesity and the weight loss undertaken to treat it.(1,2) However, the treatment of obesity is not the only potential indication for caloric restriction (CR).For years, some individualsmany already at normal weight-have pursued CR with the desire to slow the biological rate of aging and to increase longevity.(3) This potential was explored in the Comprehensive Assessment of Long-term Effects of Reduced Intake of Energy (CALERIE) phase 2 trial, a 2-year randomized controlled trial (RCT) that tested the feasibility, safety, and efficacy of CR in nonobese young and middle-aged adults.Effects on the primary outcomes of resting metabolic rate and core body temperature have been published.(4) In this issue of the Journal of Bone and Mineral Research, Villareal and colleagues (5) report the effects of the CR intervention on bone metabolism and BMD.CALERIE phase 2 enrolled adults 20 to 50 years old with BMI 22 to 28 kg/m 2 , randomizing 218 participants to CR or ad libitum control diets.The CR intervention was designed to produce weight loss during the first year followed by weight maintenance during the second year.The CR group achieved an average 11.7% CR over the 2 years, resulting in a mean weight loss from baseline of 8.4 kg at 12 months (an 11.5% decrease) and 7.5 kg at 24 months (a 10% decrease).Weight change in the control group was negligible.Villareal and colleagues (5) show that spine and proximal femur BMD declined significantly in the CR group, with a 2% decline by 2 years.Markers of bone resorption increased at 6 and 12 months in the CR group, and the bone formation marker bone-specific alkaline phosphatase decreased at 12 and 24 months.Should we be concerned that this decline in bone mass will mean a higher risk of fracture in the future?Or, need we not be concerned because the decline is simply the skeleton's appropriate adaptation to a new, lower body weight?Before
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2181055594
FWCI: 2.524
Cites: 56
Cited by: 39
Related to: 10